{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T07:59:33Z","timestamp":1762761573587,"version":"3.37.3"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01NS073476","U01NS088034","U01NS088023","U01NS056975","U01NS059041","R01NS099653"],"award-info":[{"award-number":["U01NS073476","U01NS088034","U01NS088023","U01NS056975","U01NS059041","R01NS099653"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","epilepsybehavior.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.yebeh.2019.04.049","type":"journal-article","created":{"date-parts":[[2019,10,22]],"date-time":"2019-10-22T22:15:53Z","timestamp":1571782553000},"page":"106296","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"PB","title":["Lessons from the Established Status Epilepticus Treatment Trial"],"prefix":"10.1016","volume":"101","author":[{"given":"Hannah R.","family":"Cock","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa D.","family":"Coles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordan","family":"Elm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Silbergleit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James M.","family":"Chamberlain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James C.","family":"Cloyd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathan","family":"Fountain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shlomo","family":"Shinnar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Lowenstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robin","family":"Conwit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas P.","family":"Bleck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaideep","family":"Kapur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.yebeh.2019.04.049_bb0005","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1111\/epi.13121","article-title":"A definition and classification of status epilepticus \u2014 report of the ILAE Task Force on Classification of Status Epilepticus","volume":"56","author":"Trinka","year":"2015","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.yebeh.2019.04.049_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.eplepsyres.2010.09.003","article-title":"Prognostic factors, morbidity and mortality in tonic\u2013clonic status epilepticus: a review","volume":"93","author":"Neligan","year":"2011","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2019.04.049_bb0015","article-title":"Medical management of status epilepticus: emergency room to intensive care unit","author":"Crawshaw","year":"2019","journal-title":"Seizure"},{"issue":"1","key":"10.1016\/j.yebeh.2019.04.049_bb0020","doi-asserted-by":"crossref","first-page":"48","DOI":"10.5698\/1535-7597-16.1.48","article-title":"Evidence-based guideline: treatment of convulsive status epilepticus in children and adults: report of the Guideline Committee of the American Epilepsy Society","volume":"16","author":"Glauser","year":"2016","journal-title":"Epilepsy Curr"},{"issue":"3","key":"10.1016\/j.yebeh.2019.04.049_bb0025","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.seizure.2013.12.007","article-title":"The relative effectiveness of five antiepileptic drugs in treatment of benzodiazepine-resistant convulsive status epilepticus: a meta-analysis of published studies","volume":"23","author":"Yasiry","year":"2014","journal-title":"Seizure"},{"issue":"7","key":"10.1016\/j.yebeh.2019.04.049_bb0030","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s40263-014-0167-1","article-title":"Efficacy and safety of intravenous valproate for status epilepticus: a systematic review","volume":"28","author":"Trinka","year":"2014","journal-title":"CNS Drugs"},{"issue":"1","key":"10.1016\/j.yebeh.2019.04.049_bb0035","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s12028-012-9695-z","article-title":"Guidelines for the evaluation and management of status epilepticus","volume":"17","author":"Brophy","year":"2012","journal-title":"Neurocrit Care"},{"issue":"12","key":"10.1016\/j.yebeh.2019.04.049_bb0040","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1056\/NEJM199809173391202","article-title":"A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group","volume":"339","author":"Treiman","year":"1998","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.yebeh.2019.04.049_bb0045","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJM198507183130303","article-title":"Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic\u2013clonic seizures","volume":"313","author":"Mattson","year":"1985","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.yebeh.2019.04.049_bb0050","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1136\/jnnp.58.1.44","article-title":"Phenobarbitone, phenytoin, carbamazepine, or sodium valproate for newly-diagnosed adult epilepsy \u2014 a randomized comparative monotherapy trial","volume":"58","author":"Heller","year":"1995","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"10.1016\/j.yebeh.2019.04.049_bb0055","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/epi.12058","article-title":"Lacosamide as a new treatment option in status epilepticus","volume":"54","author":"Hofler","year":"2013","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.yebeh.2019.04.049_bb0060","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1528-1167.2012.03543.x","article-title":"Safety and tolerability of adjunctive lacosamide intravenous loading dose in lacosamide-naive patients with partial-onset seizures","volume":"54","author":"Fountain","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2019.04.049_bb0065","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1528-1167.2011.03237.x","article-title":"Established Status Epilepticus Treatment Trial (ESETT)","volume":"52","author":"Cock","year":"2011","journal-title":"Epilepsia"},{"issue":"8","key":"10.1016\/j.yebeh.2019.04.049_bb0070","doi-asserted-by":"crossref","first-page":"S130-S7","DOI":"10.1016\/j.jclinepi.2013.02.015","article-title":"Investigators EA-I. Bayesian adaptive trials offer advantages in comparative effectiveness trials: an example in status epilepticus","volume":"66","author":"Connor","year":"2013","journal-title":"J Clin Epidemiol"},{"issue":"SI","key":"10.1016\/j.yebeh.2019.04.049_bb0075","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/epi.12288","article-title":"The Established Status Epilepticus Trial 2013","volume":"54","author":"Bleck","year":"2013","journal-title":"Epilepsia"},{"issue":"10","key":"10.1016\/j.yebeh.2019.04.049_bb0080","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1164\/rccm.2107138","article-title":"The Richmond Agitation\u2013Sedation Scale \u2014 validity and reliability in adult intensive care unit patients","volume":"166","author":"Sessler","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1016\/j.yebeh.2019.04.049_bb0085","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1136\/jnnp.2005.080887","article-title":"Prognosis of status epilepticus: role of aetiology, age, and consciousness impairment at presentation","volume":"77","author":"Rossetti","year":"2006","journal-title":"J Neurol Neurosurg Psychiatry"},{"year":"2013","series-title":"WMA Declaration of Helsinki \u2014 ethical principles for medical research involving human subjects","author":"World Medical Association","key":"10.1016\/j.yebeh.2019.04.049_bb0090"},{"author":"US Department of Health and Human Services","key":"10.1016\/j.yebeh.2019.04.049_bb0095"},{"key":"10.1016\/j.yebeh.2019.04.049_bb0100","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12910-016-0092-6","article-title":"Exceptions to the rule of informed consent for research with an intervention","volume":"17","author":"Rebers","year":"2016","journal-title":"BMC Med Ethics"},{"issue":"Suppl_2","key":"10.1016\/j.yebeh.2019.04.049_bb0105","doi-asserted-by":"crossref","first-page":"A134-A","DOI":"10.1161\/circ.138.suppl_2.134","article-title":"Abstract 134: patients' perspectives on enrollment in research using the exception from informed consent: an integrated survey","volume":"138","author":"Dickert","year":"2018","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.yebeh.2019.04.049_bb0110","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/j.1553-2712.2010.00746.x","article-title":"Step-forward randomization in multicenter emergency treatment clinical trials","volume":"17","author":"Zhao","year":"2010","journal-title":"Acad Emerg Med"},{"issue":"3","key":"10.1016\/j.yebeh.2019.04.049_bb0115","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2017-4066","article-title":"Pediatric medication safety in the emergency department","volume":"141","author":"Benjamin","year":"2018","journal-title":"Pediatrics"},{"issue":"7","key":"10.1016\/j.yebeh.2019.04.049_bb0120","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1056\/NEJMoa1107494","article-title":"Intramuscular versus intravenous therapy for prehospital status epilepticus","volume":"366","author":"Silbergleit","year":"2012","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.yebeh.2019.04.049_bb0125","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1111\/j.1528-1157.1997.tb01256.x","article-title":"In whom does status epilepticus occur: age-related differences in children","volume":"38","author":"Shinnar","year":"1997","journal-title":"Epilepsia"},{"issue":"4","key":"10.1016\/j.yebeh.2019.04.049_bb0130","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/epi.12550","article-title":"ILAE official report: a practical clinical definition of epilepsy","volume":"55","author":"Fisher","year":"2014","journal-title":"Epilepsia"},{"issue":"4","key":"10.1016\/j.yebeh.2019.04.049_bb0135","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/epi.13670","article-title":"Operational classification of seizure types by the International League Against Epilepsy: position paper of the ILAE Commission for Classification and Terminology","volume":"58","author":"Fisher","year":"2017","journal-title":"Epilepsia"},{"issue":"4","key":"10.1016\/j.yebeh.2019.04.049_bb0140","doi-asserted-by":"crossref","first-page":"1528-167","DOI":"10.1111\/j.1528-1167.2009.02285.x","article-title":"Recommendation for a definition of acute symptomatic seizure","volume":"51","author":"Beghi","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2019.04.049_bb0145","series-title":"Oxford desk reference: critical care","article-title":"Antiepileptic drugs","author":"Cock","year":"2019"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505019303038?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505019303038?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,3]],"date-time":"2024-07-03T03:53:24Z","timestamp":1719978804000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505019303038"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":29,"alternative-id":["S1525505019303038"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2019.04.049","relation":{},"ISSN":["1525-5050"],"issn-type":[{"type":"print","value":"1525-5050"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lessons from the Established Status Epilepticus Treatment Trial","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2019.04.049","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106296"}}